Mohammed S. Abdel‐Maksoud

1.3k total citations
51 papers, 1.1k citations indexed

About

Mohammed S. Abdel‐Maksoud is a scholar working on Organic Chemistry, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Mohammed S. Abdel‐Maksoud has authored 51 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Organic Chemistry, 34 papers in Molecular Biology and 9 papers in Computational Theory and Mathematics. Recurrent topics in Mohammed S. Abdel‐Maksoud's work include Synthesis and biological activity (28 papers), Melanoma and MAPK Pathways (19 papers) and Computational Drug Discovery Methods (9 papers). Mohammed S. Abdel‐Maksoud is often cited by papers focused on Synthesis and biological activity (28 papers), Melanoma and MAPK Pathways (19 papers) and Computational Drug Discovery Methods (9 papers). Mohammed S. Abdel‐Maksoud collaborates with scholars based in Egypt, South Korea and United Arab Emirates. Mohammed S. Abdel‐Maksoud's co-authors include Chang‐Hyun Oh, Kyung Ho Yoo, Mahmoud M. Gamal El‐Din, Mohammed I. El‐Gamal, Eslam M.H. Ali, Usama M. Ammar, Mohammed I. El–Gamal, Kyung‐Tae Lee, Rasha M. Hassan and Chang-Hyun Oh and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Mohammed S. Abdel‐Maksoud

50 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mohammed S. Abdel‐Maksoud Egypt	22	755	545	138	120	109	51	1.1k
Rabah A.T. Serya Egypt	20	671 0.9×	429 0.8×	91 0.7×	69 0.6×	178 1.6×	38	1.0k
Ashraf H. Bayoumi Egypt	25	1.1k 1.5×	538 1.0×	141 1.0×	98 0.8×	156 1.4×	50	1.4k
Mohamed Hagras Egypt	18	512 0.7×	384 0.7×	64 0.5×	44 0.4×	73 0.7×	40	818
Riham F. George Egypt	25	1.2k 1.6×	576 1.1×	167 1.2×	58 0.5×	166 1.5×	76	1.6k
Ewa Maj Poland	20	336 0.4×	469 0.9×	43 0.3×	72 0.6×	256 2.3×	43	999
Tamer Nasr Egypt	16	684 0.9×	345 0.6×	62 0.4×	23 0.2×	113 1.0×	48	1.0k
Amer Ali Abd El‐Hafeez Egypt	15	304 0.4×	318 0.6×	40 0.3×	38 0.3×	159 1.5×	35	679
Adel Ghiaty Egypt	17	493 0.7×	317 0.6×	44 0.3×	36 0.3×	52 0.5×	21	659
Aysun Çapcı Germany	15	358 0.5×	342 0.6×	73 0.5×	18 0.1×	84 0.8×	19	754

Countries citing papers authored by Mohammed S. Abdel‐Maksoud

Since Specialization

Citations

This map shows the geographic impact of Mohammed S. Abdel‐Maksoud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed S. Abdel‐Maksoud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed S. Abdel‐Maksoud more than expected).

Fields of papers citing papers by Mohammed S. Abdel‐Maksoud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammed S. Abdel‐Maksoud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed S. Abdel‐Maksoud. The network helps show where Mohammed S. Abdel‐Maksoud may publish in the future.

Co-authorship network of co-authors of Mohammed S. Abdel‐Maksoud

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammed S. Abdel‐Maksoud. A scholar is included among the top collaborators of Mohammed S. Abdel‐Maksoud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammed S. Abdel‐Maksoud. Mohammed S. Abdel‐Maksoud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abdel‐Maksoud, Mohammed S., et al.. (2025). Design and synthesis of novel cyclohexanecarboxamides with anticonvulsant effect by activating Nrf2-ARE pathway. Bioorganic Chemistry. 159. 108357–108357. 1 indexed citations

Hassan, Rasha M., et al.. (2025). Peroxisome proliferator-activated receptors (PPARs) agonists as promising neurotherapeutics. Bioorganic Chemistry. 156. 108226–108226.

Abdel‐Maksoud, Mohammed S., et al.. (2024). Anticancer and anti-inflammatory effects of novel ethyl pyrazole derivatives having sulfonamide terminal moiety. Bioorganic Chemistry. 153. 107825–107825. 6 indexed citations

Abdel‐Maksoud, Mohammed S., Eslam M.H. Ali, Usama M. Ammar, et al.. (2023). Evaluation of novel pyrazol-4-yl pyridine derivatives possessing arylsulfonamide tethers as c-Jun N-terminal kinase (JNK) inhibitors in leukemia cells. European Journal of Medicinal Chemistry. 261. 115779–115779. 8 indexed citations

El‐Behairy, Mohammed Farrag, Mohamed M. Khalifa, Mohamed S. Nafie, et al.. (2023). Design and synthesis of novel rigid dibenzo[ b,f ]azepines through ring closure technique as promising anticancer candidates against leukaemia and acting as selective topoisomerase II inhibitors and DNA intercalators. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2157825–2157825. 19 indexed citations

Nocca, Giuseppina, Alessandro Arcovito, Nermeen A. Elkasabgy, et al.. (2023). Cellulosic Textiles—An Appealing Trend for Different Pharmaceutical Applications. Pharmaceutics. 15(12). 2738–2738. 7 indexed citations

Zaraei, Seyed–Omar, Saif Ullah, Hanan S. Anbar, et al.. (2022). Design and synthesis of new adamantyl derivatives as promising antiproliferative agents. European Journal of Medicinal Chemistry. 246. 114958–114958. 7 indexed citations

Ali, Eslam M.H., Mohammed S. Abdel‐Maksoud, Usama M. Ammar, et al.. (2021). Design, synthesis, biological evaluation, and docking studies of novel (imidazol-5-yl)pyrimidine-based derivatives as dual BRAFV600E/p38α inhibitors. European Journal of Medicinal Chemistry. 215. 113277–113277. 24 indexed citations

Abdel‐Maksoud, Mohammed S., Mohammed I. El–Gamal, Mahmoud M. Gamal El‐Din, et al.. (2021). Discovery of New Imidazo[2,1-b]thiazole Derivatives as Potent Pan-RAF Inhibitors with Promising In Vitro and In Vivo Anti-melanoma Activity. Journal of Medicinal Chemistry. 64(10). 6877–6901. 25 indexed citations

10.

Abdel‐Maksoud, Mohammed S., Rasha M. Hassan, Aida A. El‐Azzouny, Mohamed N. Aboul‐Enein, & Chang‐Hyun Oh. (2021). Anticancer profile and anti-inflammatory effect of new N-(2-((4-(1,3-diphenyl-1H-pyrazol-4-yl)pyridine sulfonamide derivatives. Bioorganic Chemistry. 117. 105424–105424. 26 indexed citations

11.

Ammar, Usama M., Mohammed S. Abdel‐Maksoud, Eslam M.H. Ali, et al.. (2020). Modification of imidazothiazole derivatives gives promising activity in B-Raf kinase enzyme inhibition; synthesis, in vitro studies and molecular docking. Bioorganic & Medicinal Chemistry Letters. 30(20). 127478–127478. 17 indexed citations

12.

Alkhaldi, Abdulsalam A. M., Mohammad M. Al‐Sanea, Alessio Nocentini, et al.. (2020). 3-Methylthiazolo[3,2-a]benzimidazole-benzenesulfonamide conjugates as novel carbonic anhydrase inhibitors endowed with anticancer activity: Design, synthesis, biological and molecular modeling studies. European Journal of Medicinal Chemistry. 207. 112745–112745. 62 indexed citations

13.

Ali, Eslam M.H., et al.. (2020). Design, synthesis, and biological evaluation of novel imidazole derivatives possessing terminal sulphonamides as potential BRAFV600Einhibitors. Bioorganic Chemistry. 106. 104508–104508. 28 indexed citations

14.

Ali, Eslam M.H., Mohammed S. Abdel‐Maksoud, Rasha M. Hassan, et al.. (2020). Design, synthesis and anti-inflammatory activity of imidazol-5-yl pyridine derivatives as p38α/MAPK14 inhibitor. Bioorganic & Medicinal Chemistry. 31. 115969–115969. 28 indexed citations

15.

Ammar, Usama M., et al.. (2020). Structural optimization of imidazothiazole derivatives affords a new promising series as B-Raf V600E inhibitors; synthesis, in vitro assay and in silico screening. Bioorganic Chemistry. 100. 103967–103967. 21 indexed citations

16.

Abdel‐Maksoud, Mohammed S., Mohammed I. El–Gamal, Mahmoud M. Gamal El‐Din, & Chang Hyun Oh. (2018). Design, synthesis,in vitroanticancer evaluation, kinase inhibitory effects, and pharmacokinetic profile of new 1,3,4-triarylpyrazole derivatives possessing terminal sulfonamide moiety. Journal of Enzyme Inhibition and Medicinal Chemistry. 34(1). 97–109. 29 indexed citations

17.

Abdel‐Maksoud, Mohammed S., Mohammed I. El‐Gamal, Mahmoud M. Gamal El‐Din, et al.. (2015). Design, synthesis, in vitro antiproliferative evaluation, and kinase inhibitory effects of a new series of imidazo[2,1-b]thiazole derivatives. European Journal of Medicinal Chemistry. 95. 453–463. 45 indexed citations

18.

Abdel‐Maksoud, Mohammed S., et al.. (2015). Genetic characterisation of multidrug-resistant <i>Salmonella enterica</i> serotypes isolated from poultry in Cairo, Egypt. SHILAP Revista de lepidopterología. 4(1). 1–7. 31 indexed citations

19.

El‐Gamal, Mohammed I., Mohammed S. Abdel‐Maksoud, Mahmoud M. Gamal El‐Din, et al.. (2014). Cell‐Based Biological Evaluation of a New Bisamide FMS Kinase Inhibitor Possessing Pyrrolo[3,2‐c]pyridine Scaffold. Archiv der Pharmazie. 347(9). 635–641. 13 indexed citations

20.

El‐Gamal, Mohammed I., et al.. (2012). Design, synthesis, and antiproliferative activity of new 1H-pyrrolo[3,2-c]pyridine derivatives against melanoma cell lines. Part 2. Bioorganic & Medicinal Chemistry Letters. 22(13). 4362–4367. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact